Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Revenue

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹5,617 Cr₹5,665 Cr₹3,625 Cr₹4,401 Cr₹3,463 Cr

What is the latest Revenue of GLAND PHARMA ?

The latest Revenue ratio of GLAND PHARMA is ₹5,617 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹5,617 Cr
Mar2025₹5,665 Cr
Mar2024₹3,625 Cr
Mar2023₹4,401 Cr
Mar2022₹3,463 Cr

How is Revenue of GLAND PHARMA Trending?

Years Revenue % Change
Mar2026 ₹5,617 Cr
-0.85
Mar2025 ₹5,665 Cr
56.29
Mar2024 ₹3,625 Cr
-17.64
Mar2023 ₹4,401 Cr
27.08
Mar2022 ₹3,463 Cr -

Compare Revenue of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,775.8 Cr -0.7% 0.8% 44.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,478.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹253,031.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,216.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹112,205.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,040.0 Cr 0.9% 4% -7.6% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.7%

0.8%

44.5%

SENSEX

-2.8%

-6.1%

-11.9%


You may also like the below Video Courses